Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration

Autor: Jindal, Siddharth, Pedersen, Dennis Vestergaard, Gera, Nimish, Chandler, Julian, Patel, Rekha, Neill, Alyssa, Cone, Josh, Zhang, Yuchun, Yuan, Chao-Xing, Millman, Ellen E., Carlin, Dan, Puffer, Bridget, Sheridan, Douglas, Andersen, Gregers Rom, Tamburini, Paul
Zdroj: In Molecular Immunology January 2024 165:29-41
Databáze: ScienceDirect